Small Animal GA Flashcards

1
Q

what stage of GA do you want to maintain

A

stage 3; surgical anesthesia

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

phase 1 of GA; period, what can the patient still do, end goal, purpose of ET tube, ideal scenario

A
  • This is the period between the initial administration of the anesthetic and the loss of consciousness.
  • The patient can still hear and respond to stimuli but pain threshold increases (Analgesia without amnesia)
  • End goal at the end of this phase is endotracheal intubation once appropriate signs achieved
  • ET tube for airway protection, ventilation and maintenance delivery
  • Ideal scenario: Quick and smooth loss of consciousness, good muscle relaxation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

phase 2; type of phase, what happens, ideal scenario

A
  • Excitement Phase (Potential Phase)
  • Loss of consciousness but marked excitement occurs
  • Rough induction, resistance, unable to intubate
  • Additional induction agents needed
  • Vomiting, dilated pupil, tachycardia, irregular respiration, spastic movements may be seen
  • Ideal scenario: This phase is not seen
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

what is phase 2 more common with? (4)

A
  • Barbiturates
  • Mask and chamber induction
  • Inadequate dose of administration of induction agents
  • Poorly sedated patients (Premedication decreases incidence and duration)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

phase 3; stage of anesthesia, patient, appearance, levels

A
  • Maintenance or Surgical Anesthesia
  • Patient is unconscious with good muscle relaxation present
  • Eyes in ventromedial position and no nystagmus (in SA)
  • Levels of depth based on level of the maintenance anesthetic agent being delivered for the surgical or diagnostic need; Light, Medium, Deep
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

phase 4; what does it mean if pt is in this phase, signs, when its increased, ideal scenario

A
  • Overdose = too Deep
  • Severe hypoventilation or apnea
  • Significant cardiovascular depression
  • Progresses to arrest if not corrected
  • Greater potential in critical ASA 4-5 patients

Ideal scenario: avoid this stage with proper monitoring and patient stabilization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

purpose vs reality of fasting in small animals

A
  • Objective: Reduce the volume of stomach contents, which would, in turn, reduce the risk of reflux, regurgitation, and aspiration.
  • Reality:
  • Duration of fasting does not consistently affect the volume of stomach contents
  • Gastric emptying is affected by the specific composition of food ingested
  • Dry food takes longer digest than canned food, which takes longer than liquids
  • Breed and conformation, medications, and many other factors also influence gastric emptying
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

what type of process is regurg/reflux

A

▪ Passive process: gastric content moves up the esophagus and passes the upper esophageal sphincter (LES) to exit through mouth or nose (Do not confuse with GER)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

what can regurg/reflux lead to

A
  • Aspiration pneumonia
  • Ulcerative esophagitis and stricture formation (1 in 1000)
  • Nasal and pharyngeal irritation
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

how long to fast animals and exceptions

A
  • In healthy patients 4-6 hours
  • Exceptions
    1. Neonates and diabetic patients
    (shorter fasting)
    2. Brachycephalic or past history
    (longer fasting)
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

why does preanesthetic condition impact the effects of induction and inhalant anesthetics

A

o There is NO safe anesthetic
o All have a level of negative Cardiovascular or Respiratory effects
o Pharmacology trials done in research animals (Healthy)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

preanesthetic conditions requiring stabilization (13)

A

-Significant dehydration (>5%)
-Blood loss > 10% blood volume
-Anemia (PCV<20%)
-Hypoproteinemia (Albumin< 20g/L)
-Severe Acidemia (pH < 7.1)
-Hypokalemia (< 2.5 mmol/L)
-Hyperkalemia (>6 mmol/L)
-Significant intrathoracic disease (Pneumothorax, pleural effusion, chylothorax…)
-Oliguria, anuria investigate cause
-Congestive heart failure
-Severe cardiac arrhythmias
-Control: Seizures, High ICP, Diabetes, Hyper/Hypothyroidism,
hyper/hypoadrenocorticism

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

_____ of the patient is required to reduce chance of arrest or significant morbidity

A

stabilization

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Use of premedication will ______ the dose of induction and
maintenance agents

A

decrease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

induction agents (7)

A
  1. Propofol
  2. Alfaxalone
  3. Ketamine + Benzodiazepine
  4. Mask/Tank Inhalant
  5. Opioid and Benzodiazepine (neuroleptic induction)
    * In very critical cases, ASA 4-5, Will not work in healthy patient
  6. Barbiturates - not as common now
  7. Etomidate and Telazol = not available in Canada
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

propofol advantages (7)

A
  • Sedation achieved at low doses
  • Rapid onset and short duration
  • Titration to effect allows for smooth inductions
  • Decreases CMRO2 and can be used to treat seizures
  • Can be given as constant rate infusion (CRI) – TIVA ; To maintain general anesthesia (good recoveries)
  • Non-irritant if injected perivascular
  • Cardio-respiratory effects minimal with clinical doses in stabilized patients; Side effects can be minimized by titration and slow administration
15
Q

what patients can propofol be used in

A

o Liver disease patients (Extra-hepatic metabolism)
o Neonates
o Renal disease patients
o Pregnancy and C-section
o Patients with increased ICP or IOP

16
Q

disadvantages of propofol (7)

A

Potential negative CV effects of lowered BP, HR and cardiac output
- Dangerous in critical patients with ongoing cardiovascular instability

Apnea, reduced minute ventilation and PaO2
- More common: high doses and rapid administration
- More dangerous: when oxygen not available

Paddling, rigidity and opisthotonus can be seen with induction
- Cholinergic effect (do not confuse with excitement or seizure)
- Usually self limiting and low incidence (1.2-9%)

Heinz body formation with repeated daily use in cats
- More than 5 consecutive days

Cannot be given IM (pain at injection and poor absorption

Large volumes required in larger animals

Have to discard/waste unused volumes after 12 hours
- New formulations up to 28 days

17
Q

alfaxalone advantages (6)

A
  • Sedation achieved at low doses
  • Rapid onset and short duration
  • Titration to effect allows for smooth inductions
  • Decreases CMRO2 and can be used when ICP is high
  • Can be given as constant rate infusion (CRI) – TIVA ; To maintain general anesthesia Non-irritant if injected perivascular
  • Cardio-respiratory effects minimal with clinical doses in stabilized patients; Side effects can be minimized by titration and slow administration
18
Q

alfax uses

A

o Minimal effects on liver and kidney
o Safe in dogs and cats <12 weeks
o Pregnancy and C-section
o Patients with increased ICP or IOP

19
Q

disadvantages of alfax

A
  • Potential negative CV effects of lowered BP, HR and cardiac output
  • Dangerous in critical patients with ongoing cardiovascular instability
  • Apnea, reduced minute ventilation and PaO2
  • More common: high doses and rapid administration
  • More dangerous: when oxygen not available
  • Tremors, ataxia, opisthotonus-like posture and transient paddling can be seen at recovery in both dogs and cats
  • Large volumes required in larger animals (especially for IM)
20
Q

most common induction agent

A

benzos …. but opioid, lidocaine or ketamine can also be used

21
Q

goal of co-induction agents

A
  • Goal is to reduce dose and volume of and potentially the negative
    cardiorespiratory effects
  • Co-induction does smooth the induction process allowing ET intubation
21
Q

ketamine/benzo advantages

A
  • Titration to effect is possible
  • Longer action than propofol or alfaxalone
  • Low doses can be used for sedative effect
  • No apnea
  • Sympathomimetic effects of ketamine
    o Which maintains or increases HR, BP and CO. An advantage in healthy animals as pre-medicant agents and inhalants will lower these parameters
  • Possible increase in HR may not be ideal in cases already
    tachycardic or with certain cardiac diseases
  • Tachyarrhythmia potential
  • Salivation potential
  • Increases CMRO2 (Not ideal induction agent if brain disease)
  • A sick patient without remaining sympathetic stores will have myocardial depression and reduced CO from the ketamine
  • Both Ketamine and benzos are scheduled drugs
  • Can not be used to maintain anesthesia for long periods
22
Q

advantages of mask/tank (4)

A
  • Allows for pre-oxygenation and oxygen administration
  • Option is IV access is not possible
  • Safer for personnel when dealing with wildlife
  • Quick and smoother induction in birds
23
Q

disadvantages of mask/tank (10)

A
  • Dose rises quickly
  • Titration to effect NOT possible
  • Stressful and with long excitement phase
  • No IV access
  • No airway support or protection as go through excitement phase
  • Require the use of costly anesthetic machine, vaporizer, breathing system
  • Must have equipment knowledge to be able to use safely
  • Health and Safety of Staff
  • Scavenging required to prevent pollution
  • Dose dependent cardiovascular and respiratory depression
24
Q

neuroleptic induction; combo, safety, who wont it work in, environment

A
  • Opioid/Benzodiazepine Combinations to enable ET intubation
  • Most cardiovascular safe option in compromised Dog
  • ASA category 4-5 population
  • Will not work in healthy dog
  • Does not allow for ET intubation even in critical cats
  • IV dose of hydromorphone, methadone or fentanyl followed
    immediately by midazolam or diazepam
  • Lidocaine IV can be included to supress cough
  • Quiet environment needed since animal is not unconscious
25
Q

advtanges of barbituates (thiopental) (2)

A

-cheap
-short onset

26
Q

disadvtanges of barbituates (thiopental) (7)

A
  • Negative CV effects: reduced BP, CO, arrhythmias likely
  • Bigeminal rhythm (normal complex, then VPC)
  • Apnea, hypoventilation
  • Excitement on induction possible
  • Irritating if given perivascular = tissue slough
  • Scheduled, currently low availability
  • Prolonged recovery if repeated doses in sight hounds or fat patients
27
Q

4 steps in the induction process

A
  1. Assess Sedation level; IV access; Equipment prepared
  2. Assess cardiorespiratory status (HR, MM colour, RR, monitors, pre-oxygenate)
  3. Initial first “bolus” volume (mls) of induction agent
    ~Based on sedation level
    ~Each drug has a dose rangewith general guidelines
    ~Assess depth level to proceed to ET intubation
    ~Give appropriate additional incremental IV boluses if needed (titration)
  4. Intubate, perform ET cuff inflation, transfer to inhalant/maintenance anesthesia and permit positioning
28
Q

appropriate signs of intubation (7)

A
  • Relaxation & lowering of head
  • Eye rotation
  • Loss of lateral palpebral
  • Relaxed jaw tone
  • No tongue movement
  • No response to handler opening mouth
  • No response to laryngoscope placement
29
Q

how do you know you are in the right hole when intubation? (6)

A
  • Direct visualization
  • See condensation, or feel breath at end of ET tube
  • See anesthetic bag movement once attached to circuit
  • When you ‘bag’ or breathe for animal the chest moves
  • Presence of CO2 wave in capnograph
  • Can perform ET cuff inflation… If you cannot get a seal and still hear air leakage – you are in the esophagus not trachea
30
Q

advantages of inhalants (7)

A
  • Added patient safety
  • Administered with oxygen through endotracheal tube (ET)
  • May be delivered with mask (but less safe)
  • Act rapidly and rapid recoveries (no accumulation)
  • Quick changes of anesthetic depth and recovery
  • Minimal metabolism by liver or kidneys
  • Produce less cardiac arrhythmias compared to older inhalants
31
Q

disadvantages of inhalants (6)

A
  • Require the use of costly anesthetic machine, vaporizer, breathing system and ET tubes
  • Must have equipment knowledge to be able to use safely
  • Health and Safety of Staff
  • Scavenging required to prevent pollution
  • Dose dependent cardiovascular and respiratory depression
  • Requires careful monitoring
32
Q

what does iso/sevo MAC level decrease with (5)

A

o Pre-medication, intravenous agents, analgesics
o Age: lower in geriatric and neonates
o Hypothermia
o Pregnancy
o Concurrent illness

33
Q

criteria for extubation for dogs

A
  • Dogs: STRONG medial palpebral and/or swallow reflex indicate patient ready to extubate
  • May also see dogs stretch move legs or head
  • Return of swallow important if you have seen gastro-esophageal reflux
  • Brachycephalic dogs have different criteria for extubation!; Keep ET tube until completely awake, head up
34
Q

criteria for extubation for cats

A
  • Extubate when a medial palpebral reflex present
  • Look also for ear flick, whisker reflex, tongue curl
  • Extubate earlier than return of swallow reflex, or movement to prevent laryngospasm at recovery